Page 21 - Oligonucleotide Therapeutics Solution Guide
P. 21

Characteristic analysis
 Quality Control

 Molecular Weight Confirmation & Quantitation  LCMS-9030




                 Features
 Molecular Weight Determination and Quantitation of Oligonucleotide
               LCMS-9030 is a quadrupole time-of-flight (Q-TOF) mass spectrometer with two types of ion mass separation mechanisms: quadrupole and time-of-  Modification
 Therapeutics Using Quadrupole Time-of- Flight Mass Spectrometer LCMS-9030  flight. Unique technologies abound, such as technology to improve ion utilization efficiency, processing technology to produce high-strength fine   Target selection
               grid electrodes, high-precision temperature control, and optimization of potential distribution, enabling data acquisition with both high sensitivity
 click here    and high resolution while maintaining stable mass accuracy.
               Since oligonucleotide therapeutics have a molecular weight of 6000 or more at 20 bases, high-precision mass spectrometers such as Q-TOF mass
               spectrometers are used to confirm the molecular weight.
 •    High-resolution mass spectra provide more accurate molecular weight
 confirmation.
 benefits  •    Achieves stable mass accuracy without frequent mass calibration.                                   Excision



  Methods and Results                                                                                            Unprotected  Oligomer synthesis

 Sample  5'-mG-mC*-mC*-mU*-mC*-dA-dG-dT-dC*-dT-dG-dC*-dT-
 dT-dC*-mG-mC*-mA-mC*-mC*-3‘
 m: 2‘-O-(2-Methoxyethyl) nucleoside (2-MOE)
 * : 5-methylated derivatives of C and U
 D : 2’-deoxyribonucleoside
 Monoisotopic mass: 6431.7239
 Conc., Volume 1 ~ 1000 ng/mL, 5 µL
 Preparation  Dilution in ultrapure water to the concentrations above.
 Analytical   The HPLC and MS analysis conditions are shown in
 Conditions  Table 1. In this analysis, HFIP (1,1,1,3,3,3-Hexafluoro-2-propanol)                                 Purification
 and DIPEA (N, N-diisopropylethylamine) were used in the mobile
 phase to allow highly sensitive measurement to be performed.
 Results  Figure 1 shows the mass spectrum extracted from the scan mode
 data. In the mass spectrum, multi-charged ions such as those at   Figure 1   Mass Spectra of Oligonucleotide Therapeutics
 m/z 1071.6, 918.4 and 803.5 were detected.
 The m/z values of these multi-charged ions were deconvoluted
 and Figure 2 shows the results of molecular mass calculation. As
 shown in the deconvolution spectrum, the monoisotopic mass
 was 6431.72 with a mass error of 3 mDa (0.05 ppm).
 The calibration curve is shown in Figure 3 insert, The calibration
 curve was prepared from 1 - 1000 ng/mL. The correlation
 2
 coefficient (r ) was 0.996. Figure 3 shows representative
 chromatograms obtained using multiple reaction monitoring
 (MRM) mode. The octavalent ion at m/z
 803.4626 was selected as a precursor ion. The product
 ion at m/z 94.9358 (PSO2-) was used for quantitation.  Simple Ionization Unit                                   Quality Control
 Table 1   Analysis Conditions  In addition to the standard ESI ionization unit,                                   Characteristic analysis
 [HPLC conditions] (Nexera)  optional APCI and Dual Ion Source (DUIS) probes
 Column:  Shim-pack Scepter C18 (75 mm × 2.0 mm I.D.,1.9 µm)  are available for the LCMS-9030 to meet various
 Mobile phases:  A)50 mmol/L HFIP and 10 mmol/L DIPEA    Figure 2   Deconvolution spectra  analytical needs. Shimadzu's DUIS offers an
 B)Acetonitrile
 Gradient Program  B5% (0-0.5 min) – 15%(0.5-6 min)  efficient combination of ESI and APCI ionization
 Flow rate :  0.2 mL/min  capabilities.
 Column Temp. :  50 °C
 Injection volume :  5 µL
 [MS conditions] (LCMS-9030)                                                                                     DDS
 Ionization:  ESI(Negative mode)
 Probe Voltage:  -3 kV  Calibrant Delivery                                                                         Pharmacokinetics
 Mode:  Full-scan (m/z 500-3000)
 MRM(803.4626>94.9358)  System (CDS)
 Nebulizing gas flow:  3.0 L/min
 Drying gas flow:  10.0 L/min  The CDS allows calibration standards to be introduced via a separate ionization probe that
 Heating gas flow:  10.0 L/min  functions independently from the main probe. This optional sub-ionization unit is installed in the
 DL Temp.:  250 °C  main probe housing and is available for all probe types (ESI/APCI/DUIS). By having two probes
 Heat Block Temp.:  400 °C
 Interface Temp.:  350 °C  Figure 3   MRM Chromatograms of Oligonucleotide Therapeutics  and Calibration Curve  in one system, high-concentration calibration standards can be introduced only when needed
               without switching flow lines, and are kept in isolation from the sample stream, eliminating
               contamination.
  Conclusions                                                                                                    Other

 Accurate mass spectrometry using the Q-TOF mass spectrometer LCMS-9030 determined the molecular mass with an error of 0.05 ppm.
 Additionally, linearity was observed within a range of 1 - 1000 ng/mL.



 20                                                                                                               21
 index                                                                                                   index
   16   17   18   19   20   21   22   23   24   25   26